other biological processes are regulated by this pathway? Moreover, what is the biological function of APP, an issue that has been debated for decades, and why is expression of APP but not of APLP1 or APLP2 increased by ApoE signaling? These and other questions raised by the present studies provide fertile grounds for future advances in understanding not only brain signaling pathways, but also their contribution to AD pathogenesis.
